Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells

American Journal of Pathology

Volumn 154, Issue 5, 1999, Pages 1503-1512

  Moore, Bethany B ^a   Arenberg, Douglas A ^a   Stoy, Kevin ^b   Morgan, Tamara ^b   Addison, Christina L ^a   Morris, Susan B ^a   Glass, Mary ^a   Wilke, Carol ^a   Xue, Ying Ying ^a   Sitterding, Stephanie ^a   Kunkel, Steven L ^b   Burdick, Marie D ^a   Strieter, Robert M ^a,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; INTERLEUKIN 8;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CARCINOGENESIS; CELL PROLIFERATION; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 0032929830     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65404-1     Document Type: Article

References (36)

1. Parker S, Tong T, Bolden S, Wingo P: Cancer statistics, 1996. Cancer J Clin 1996, 46:5-27
2. Maiorana A, Gullino PM: Acquisition of angiogenic capacity and neoplastic transformation in the rat mammary gland. Cancer Res 1978, 38:4409-4414
3. Bouck N: Tumor angiogenesis: the role of oncogenes and tumor suppressor genes. Cancer Cells 1990, 2:179-185
4. Walz A, Kunkel SL, Stricter RM: CXC chemokines-an overview: chemokines in disease. Edited by AE Koch, RM Strieter. Austin, TX, R.G. Landes, 1996, pp 1-26
5. Strieter RM, Kunkel SL: Chemokines and the lung. Lung: Scientific Foundations, 2nd edition. R Crystal, J West, E Weibel, P Weibel. New York, Raven Press, 1997, pp 155-186
6. Baggiolini M, Dewald B, Walz A: Interleukin-8 and related chemotactic cytokines. Inflammation: Basic Principles and Clinical Correlates. Jl Gallin, IM Goldstein, R Snyderman. New York, Raven Press, Ltd., 1992, pp 247-263
7. Miller MD, Krangel MS: Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. Crit Rev lmmunol 1992, 12:17-46
8. Taub DD, Oppenheim JJ: Chemokines, inflammation, and immune system. Therapeutic Immunol 1994, 1:229-246
9. Bleul CC, Farzan M, Choe H, Parolin C, Clark-Lewis I, Sodroski J, Springer TA: The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 1996, 382:829-833
10. Strieter RM, Polverini PJ, Kunkel SL, Arenberg DA, Burdick MD, Kasper J, Dzuiba J, Van Damme J, Walz A, Marriott D, Chan S, Roczniak S, Shanafelt A: The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem 1995, 270:27348-27357
11. Strieter RM, Kunkel SL, Shanafelt AB, Arenberg DA, Koch AE, Polverini PJ: CXC chemokines in regulation of angiogenesis. Chemokines in Disease. AE Koch, RM Strieter. Austin, TX, R.G. Landes, 1996, pp 195-210
12. Smith DR, Polverini PJ, Kunkel SL, Orringer MB, Whyte RI, Burdick MD, Wilke CA, Strieter RM: Inhibition of IL-8 attenuates angiogenesis in bronchogenic carcinoma. J Exp Med 1994, 179:1409-1415
13. Arenberg DA, Kunkel SL, Polverini PJ, Glass M, Burdick MD, Strieter RM: Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. J Clin Invest 1996, 97:2792-2802
14. Kitadai Y, Haruma K, Sumii K, Yamamoto S, Ue T, Yokozaki H, Yasui W, Ohmoto Y, Kajiyama G, Fidler I, Tahara E: Expression of interleukin-8 correlates with vascularity in human gasric carcinomas. Am J Pathol 1998, 152:93-100
15. Yoneda J, Kuniyasu H, Crispens M, Price J, Bucana C, Fidler I: Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice. J Natl Cancer Inst 1998, 90:447-454
16. Ferrer F, Miller L, Andrawis R, Kurtzman S, Albertsen P, Laudone V,. Kreutzer D: Angiogenesis and prostate cancer: in vivo and in vitro expression of angiogenesis factors by prostate cancer cells. Urology 1998, 51:161-167
17. Luan J, Shattuck-Brandt R, Hagnegahdar H, Owen J, Strieter R, Burdick M, Nirodi C, Beaauchamp D, Johnson K, Richmond A: Mechanism and biological significance of constitutive expression of MGSA/GRO chemokines in malignant melanoma tumor progression. J Leukoc Biol 1997, 62:588-597
18. Arenberg DA, Kunkel SL, Burdick MD, Polverini PJ, Strieter RM: Treatment with anti-IL-8 inhibits non-small cell lung cancer tumor growth (meeting abstract). J Invest Med 1995, 43:479A
19. Arenberg DA, Kunkel SL, Polverini PJ, Morris SB, Burdick MD, Glass M, Taub DT, Iannetoni MD, Whyte RI, Strieter RM: Interferon-γ-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases. J Exp Med 1996, 184:981-992
20. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM, Elner SG, Strieter RM: Interleukin-8 (IL-B) as a macrophage-derived mediator of angiogenesis. Science 1992, 258:1798-1801
21. Strieter RM, Kunkel SL, Elner VM, Martonyl CL, Koch AE, Polverini PJ, Elner SG: Interleukin-8: a corneal factor that induces neovascularization. Am J Pathol 1992, 141:1279-1284
22. Kaighn M, Narayan N, Ohnuki Y, Lechner J, Jones L: Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 1979, 17:16-23
23. Mickey D, Stone K, Wunderli H, Mickey G, Bollmer R, Paulson D: Heterotransplantation of a human prostatic adenocarcinoma cell line in nude mice. Cancer Res 1977, 37:4049-4058
24. Horoszewicz J, Leong S, Kawinski D, Karr J, Tosenthal H, Chu T, Mirand E, Murphy AG: LNCaP model of human prostatic carcinoma. Cancer Res 1983, 43:1809-1818
25. Arenberg D, Keane M, DiGiovine B, Kunkel S, Morris S, Xue Y, Burdick M, Glass M, Iannettoni M, Strieter R: Epithetial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer. J Clin Invest 1998, 102:465-472
26. Greene G, Kitadai Y, Pettaway C, Eschenbach AV, Bucana C, Fidler I: Correlation of metastasis-related gene expression with metastatic potential in human prostate carcinoma cells implanted in nude mice using an in situ messenger RNA hybridization technique. Am J Pathol 1997, 150:1571-1582
27. Simonet WS, Hughes TM, Nguyen HQ, Trebasky LD, Danilenko DM1 Medlock ES: Long term impaired neutrophil migration in mice overexpressing human interleukin-8. J Clin Invest 1994, 94:1310-1319
28. Richards B, Eisma R, Spiro J, Lindquist R, Kreutzer D: Coexpression of interleukin-8 receptors in head and neck squamous cell carcinoma. Am J Surg 1997, 174:507-512
29. Youngs S, Ali S, Taub D, Rees R: Chemokines induce migrational responses in human breast carcinoma cell lines. Int J Cancer 1997, 71:257-266
30. Holmes W, Lee J, Kuang W, Rice G, Wood W: Structure and functional expression of a human interleukin-8 receptor. Science 1991, 253:1278-1280
31. Cacalano G, Lee J, Kiikly K, Ryan A, Pitts-Meek S, Hultgren B, Wood W, Moore M: Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog. Science 1994, 265:682-684
32. Siegsmund MJ, Yamazaki H, Pastan I: Interleukin-6 receptor mRNA in prostate carcinomas and benign prostate hyperplasia. J Urol 1994, 151:1396-1399
33. Okamoto M, Lee C, Oyasu R: Interleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitro. Cancer Res 1997, 57:141-146
34. Lim D, Liu X, Sutkowski D, Braun E, Lee C, Kozlowski J: Growth of an androgen-sensitive human prostate cancer cell line. LNCaP, in nude mice. Prostate 1993, 22:109-118
35. Joseph I, Isaacs J: Potentiation of the antiangiogenic ability of linomide by androgen abation involves down-regulation of vascular endothelial growth factor in human androgen-responsive prostatic cancers. Cancer Res 1997, 57:1054-1057
36. Passaniti A, Isaacs J, Haney J, Adler S, Cujdik T, Long P, Kleinman H: Stimulation of human prostatic carcinoma tumor growth in athymic mice and control of migration in culture by extracellular matrix. Int J Cancer 1992, 51:318-324